رجوع
نطاق اليوم
KWD 24.01
KWD 25.41
نطاق 52 أسبوعًا
KWD 8.02
KWD 27.72
حجم التداول
6,816,204
متوسط 50 يوم / 200 يوم
KWD 24.58
/
KWD 20.18
الإغلاق السابق
KWD 24.44
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -53.4 | 0.3 |
| P/B | 1.9 | 2.9 |
| ROE % | -3.7 | 3.7 |
| Net Margin % | -4.9 | 3.8 |
| Rev Growth 5Y % | -0.3 | 10.0 |
| D/E | 0.6 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 27.880
+11.9%
Low: KWD 22.000
High: KWD 30.000
مكرر الربحية المستقبلي
23.7
ربحية السهم المستقبلية
KWD 1.032
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
5 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 1.525
KWD 1.502 – KWD 1.537
|
6 B | 2 |
| FY2029 |
KWD 1.440
KWD 1.418 – KWD 1.451
|
5.8 B | 4 |
| FY2028 |
KWD 1.327
KWD 0.356 – KWD 2.382
|
5.5 B | 6 |
النقاط الرئيسية
Revenue declined -0.26% annually over 5 years
Earnings declined -168.64% over the past year
Generating 284.00M in free cash flow
PEG of 0.29 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6.48%
Capital efficient — spends only 5.85% of revenue on capex
النمو
Revenue Growth (5Y)
-0.26%
Revenue (1Y)6.22%
Earnings (1Y)-168.64%
FCF Growth (3Y)55.80%
الجودة
Return on Equity
-3.67%
ROIC1.79%
Net Margin-4.92%
Op. Margin5.34%
الأمان
Debt / Equity
0.61
Current Ratio2.17
Interest Coverage1.15
التقييم
P/E Ratio
-53.40
P/B Ratio1.89
EV/EBITDA62.94
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.22% | Revenue Growth (3Y) | 3.32% |
| Earnings Growth (1Y) | -168.64% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -0.26% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4.72B | Net Income (TTM) | -232.00M |
| ROE | -3.67% | ROA | -1.74% |
| Gross Margin | 43.48% | Operating Margin | 5.34% |
| Net Margin | -4.92% | Free Cash Flow (TTM) | 284.00M |
| ROIC | 1.79% | FCF Growth (3Y) | 55.80% |
| Safety | |||
| Debt / Equity | 0.61 | Current Ratio | 2.17 |
| Interest Coverage | 1.15 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -53.40 | P/B Ratio | 1.89 |
| P/S Ratio | 2.63 | PEG Ratio | 0.29 |
| EV/EBITDA | 62.94 | Dividend Yield | 0.00% |
| Market Cap | 12.39B | Enterprise Value | 15.86B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.72B | 4.44B | 4.42B | 4.41B | 4.76B |
| Net Income | -232.00M | 338.00M | -1.23B | -78.00M | -483.00M |
| EPS (Diluted) | -0.47 | 0.68 | -2.50 | -0.15 | -0.97 |
| Gross Profit | 2.05B | 1.91B | 1.94B | 1.97B | 2.08B |
| Operating Income | 252.00M | 251.00M | 326.00M | 384.00M | 304.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 13.36B | 12.61B | 14.36B | 15.49B | 16.48B |
| Total Liabilities | 6.81B | 6.52B | 8.14B | 8.20B | 8.97B |
| Shareholders' Equity | 6.55B | 6.10B | 6.22B | 7.29B | 7.51B |
| Total Debt | 4.02B | 4.32B | 5.77B | 5.84B | 6.32B |
| Cash & Equivalents | 545.00M | 468.00M | 352.00M | 345.00M | 638.00M |
| Current Assets | 3.46B | 3.22B | 3.41B | 3.28B | 3.27B |
| Current Liabilities | 1.60B | 1.32B | 1.24B | 1.70B | 1.65B |